Sky Labs announced that it has attracted strategic investment from OMRON Ventures, the venture capital arm of OMRON Group, further strengthening a partnership aimed at global expansion, according to the company. The move accompanies a memorandum of understanding with OMRON Healthcare focused on distribution and development of Sky Labs’ ring-type, cuffless blood pressure monitor, CART BP.
Sky Labs said that CART BP enables continuous 24-hour monitoring of blood pressure including during sleep and daily activities, allowing users to track trends beyond traditional clinic settings. The company said the strategic tie-up builds on a 2024 MoU and a Japanese market distribution agreement, with a view toward scaling into new markets.
According to Sky Labs, OMRON Ventures’ investment is not only financial but also enables deeper collaboration on product development, regulatory strategy and market access. This investment is part of the company’s mission to prevent chronic disease through advanced wearable technology.
The company claims that its partnership with OMRON Healthcare, a global leader in blood pressure monitoring solutions present in over 130 countries, will expedite its market penetration and technology adoption. Sky Labs said it intends to leverage OMRON’s extensive distribution network to roll out CART BP in hospitals, clinics and consumer segments internationally.
